Evogene (EVGN) Metrics: History & Chart

Evogene Ltd.(EVGN)

Biotechnology · Rehovot, HM

$0.43+0.03 (+6.29%)

Delayed quote: Oct 6, 2026, 3:04 PM EDT

About Evogene Ltd.

Evogene Ltd., along with its subsidiaries, operates as a computational biology firm. Its core activity involves the discovery and advancement of products across diverse life-science sectors, such as human health and agriculture, primarily leveraging its proprietary Computational Predictive Biology (CPB) platform. This platform, built on deep biological insights, big data analytics, and artificial intelligence, is engineered to digitally identify and strategically guide the creation of life-science solutions derived from microbes, small molecules, and genetic components. The company's operations are structured into three primary divisions: Agriculture, Human Health, and Industrial Applications. Within the Agriculture division, Evogene works on seed traits, agricultural chemicals, and biological products aimed at improving plant yields, with efforts spanning critical crops like corn, soybean, wheat, rice, and cotton. The Industrial Applications segment focuses on enhancing castor bean seeds for use as a raw material in various industrial applications. Meanwhile, the Human Health segment is dedicated to uncovering and developing human microbiome-based treatments for conditions including immuno-oncology, gastrointestinal disorders, and antimicrobial-resistant infections. Beyond these core areas, Evogene also delivers medical cannabis products. The company maintains a global presence, conducting operations in the United States, Israel, Brazil, and other international markets. It has forged key partnerships and licensing agreements with leading agricultural enterprises, such as BASF SE, Corteva, and Bayer. Additionally, its subsidiary, Canonic Ltd., collaborates with Cannbit Ltd. on the development of innovative medical cannabis offerings. Established in 1999, Evogene Ltd. is based in Rehovot, Israel.

Rehovot, HM

52 employees

www.evogene.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Ofer Haviv

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	+6.26%
30D Total Return	-24.93%
YTD Total Return	-63.29%
1Y Total Return	-64.89%
3Y Total Return	-93.22%
5Y Total Return	-98.43%
10Y Total Return	-99.36%
15Y Total Return	-98.99%
20Y Total Return	N/A

2026	-63.29%
2025	-41.18%
2024	-77.74%
2023	+20.00%
2022	-57.32%
2021	-65.11%
2020

CAGR TTM	-64.71%
CAGR 3Y	-59.22%
CAGR 5Y	-56.46%
CAGR 10Y	-39.70%
CAGR 15Y	-26.38%
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

EVGN Valuation Metrics

EVGN Stock Price Metrics

EVGN Dividend Metrics

EVGN Growth Rate Metrics

EVGN Discounted Cash Flow Metrics

EVGN Returns By Period

EVGN Yearly Returns

EVGN Average Annual Returns By Period (CAGR)

EVGN Revenue Metrics

EVGN PE Ratio Metrics

EVGN PS Ratio Metrics

EVGN PB Ratio Metrics

EVGN Price to Free Cash Flow Ratio Metrics

EVGN Debt to Equity Ratio Metrics

EVGN PEG Ratio Metrics

EVGN FCF Yield

EVGN Earnings Yield

EVGN EBITDA Yield

EVGN OCF Yield

EVGN EV/EBIT Ratio Metrics

EVGN EV/EBITDA Ratio Metrics

EVGN EV/Assets Ratio Metrics

EVGN EV/Sales Ratio Metrics

EVGN Current Ratio Metrics

EVGN Quick Ratio Metrics

EVGN ROIC Metrics

EVGN Return on Assets Metrics

EVGN Return on Equity Metrics

EVGN Net Profit Margin Metrics

EVGN Gross Profit Margin Metrics

EVGN Tax Rate Metrics

PS Ratio	3.77
PS Ratio Avg TTM	2.12
PS Ratio Avg 3Y	1.98
Current VS TTM Avg	+77.73%
Current VS 3Y Avg	+90.05%
Current VS 5Y Avg	-96.89%

PB Ratio	6.00
PB Ratio Avg TTM	7.96
PB Ratio Avg 3Y	4.41
Current VS TTM Avg	-24.61%
Current VS 3Y Avg	+36.19%
Current VS 5Y Avg	-28.45%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	(0.64)
Debt/Equity Ratio Avg TTM	(5.92)
Debt/Equity Ratio Avg 3Y	(0.58)
Current VS TTM Avg	+89.22%
Current VS 3Y Avg	-10.22%
Current VS 5Y Avg	-383.05%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	0.02
Ev/Assets Ratio Avg TTM	0.30
Ev/Assets Ratio Avg 3Y	0.36
Current VS TTM Avg	-93.24%
Current VS 3Y Avg	-94.39%
Current VS 5Y Avg	-99.23%

Ev/Sales Ratio	0.19
Ev/Sales Ratio Avg TTM	1.52
Ev/Sales Ratio Avg 3Y	1.93
Current VS TTM Avg	-87.51%
Current VS 3Y Avg	-90.14%
Current VS 5Y Avg	-99.90%

Current Ratio	3.57
Current Ratio Avg TTM	3.58
Current Ratio Avg 3Y	3.43
Current VS TTM Avg	-0.35%
Current VS 3Y Avg	+3.83%
Current VS 5Y Avg	-31.71%

Quick Ratio	3.54
Quick Ratio Avg TTM	3.42
Quick Ratio Avg 3Y	3.33
Current VS TTM Avg	+3.24%
Current VS 3Y Avg	+6.03%
Current VS 5Y Avg	-31.28%

ROIC	(130.12%)
ROIC Avg 3Y	(67.98%)
ROIC Avg 5Y	(57.94%)
Current VS 3Y Avg	-91.39%
Current VS 5Y Avg	-124.56%
Current VS 10Y Avg	-190.61%

ROA	(67.51%)
ROA Avg TTM	(14.13%)
ROA Avg 3Y	(11.93%)
Current VS TTM Avg	-377.81%
Current VS 3Y Avg	-466.06%
Current VS 5Y Avg	-503.42%

ROE	N/A
ROE Avg TTM	N/A
ROE Avg 3Y	(213.69%)
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Net Profit Margin	(694.19%)
Net Profit Margin Avg TTM	(644.17%)
Net Profit Margin Avg 3Y	(542.17%)
Current VS TTM Avg	-7.77%
Current VS 3Y Avg	-28.04%
Current VS 5Y Avg	+28.99%

Gross Profit Margin	(6.25%)
Gross Pft Margin Avg TTM	(86.86%)
Gross Pft Margin Avg 3Y	50.37%
Current VS TTM Avg	+92.80%
Current VS 3Y Avg	-112.41%
Current VS 5Y Avg	-115.22%

Tax Rate	350.00%
Tax Rate Avg 3Y	N/A
Tax Rate Avg 5Y	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A